Special Issue "Biologics"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 January 2013)
Dr. Christine Brezden-Masley
St. Michael’s Hospital, 30 Bond Street, Room 2046, Toronto, Ontario, Canada
Interests: cytotoxic chemotherapeutics; molecular-targeted biologics; breast cancer pathophysiology; diagnostic imaging; patient safety
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access quarterly journal published by MDPI.
- novel molecular targets of cancer pathogenesist
- tumour biomarkers
- novel tyrosine kinase inhibitors
- molecular targeted monoclonal antibodies
- targets of tumorigenesis
- pathways of inhibition of tumorigenesis